What Is a Renal Function Panel and What Does It Test?

A renal function panel is a group of blood tests that measures how well your kidneys are filtering waste, maintaining electrolyte balance, and managing fluid levels. The panel typically includes serum creatinine, blood urea nitrogen (BUN), estimated glomerular filtration rate (eGFR), and a set of electrolytes such as sodium, potassium, chloride, bicarbonate, calcium, and phosphorus. Some labs bundle these slightly differently, but the core purpose is always the same: to catch kidney problems before they become severe and to monitor known kidney disease over time.

What Each Test on the Panel Actually Measures

The tests on a renal function panel fall into a few functional categories. Some track waste products that healthy kidneys filter out. Others measure electrolytes and minerals the kidneys regulate. Together they give your doctor a snapshot of kidney health from several angles.

Serum creatinine: Creatinine is a waste product generated by normal muscle metabolism. Healthy kidneys clear it efficiently, so rising levels in the blood suggest the kidneys are struggling. A typical reference range sits around 0.7 to 1.3 mg/dL for adults, though this varies by lab, age, and sex.
Blood urea nitrogen (BUN): Urea is another waste product, formed when the body breaks down protein. Like creatinine, it builds up when kidney filtration declines. BUN can also rise from dehydration or a very high-protein diet, so it is usually interpreted alongside creatinine rather than on its own.
Estimated GFR (eGFR): This is not a direct measurement but a calculation derived from your creatinine level, age, and sex. It estimates how many milliliters of blood your kidneys filter per minute. An eGFR above 90 is generally considered normal; below 60 for three months or longer points toward chronic kidney disease.
Sodium and potassium: These electrolytes are tightly regulated by the kidneys. Abnormal levels can signal kidney dysfunction or complications from medications like diuretics.
Chloride and bicarbonate (CO₂): These help maintain the acid-base balance in your blood. When kidney disease advances, the kidneys lose their ability to reclaim bicarbonate and excrete acid, which can push the blood toward metabolic acidosis.
Calcium and phosphorus: The kidneys play a central role in keeping these minerals in balance. In later stages of kidney disease, phosphorus tends to rise while calcium drops, which can damage bones and blood vessels over time.

How eGFR Is Calculated and Why the Formula Changed

Your eGFR number is the single most-used indicator of overall kidney function. For years, the standard formula included a race-based adjustment that assigned higher eGFR values to Black patients. In 2021, a major collaborative effort between the National Kidney Foundation and the American Society of Nephrology recommended switching to new equations that omit race entirely. The updated 2021 CKD-EPI creatinine equation uses only your creatinine level, age, and sex.

The change was not purely symbolic. Studies comparing the old race-inclusive equation with the new race-free version found meaningful differences in how Black patients were classified. In several cohorts, the mean eGFR for Black individuals dropped by roughly 9 to 10 points when the race adjustment was removed, pushing more people into higher-risk chronic kidney disease categories.¹ Validation work on the new equations showed that combining creatinine with a second biomarker called cystatin C produced more accurate estimates across racial groups, with smaller differences between Black and non-Black populations.²

That said, the new formula is not a universal upgrade. At least one comparative study found it was not clearly superior to older equations at estimating eGFR in people with more advanced kidney disease.³ The practical takeaway is that eGFR is always an estimate, never a direct measurement. If your result sits near a classification boundary, your doctor may order additional testing rather than relying on a single number.

Why Creatinine Alone Can Be Misleading

Creatinine is the backbone of most kidney panels, but it comes with blind spots. Because creatinine is produced by muscle, people with more lean mass naturally carry higher baseline levels. Research has confirmed that serum creatinine correlates more strongly with lean body mass than with total body weight, and that people who exercise regularly tend to have higher creatinine levels than sedentary individuals, independent of kidney health.⁴ In practice, this means a muscular 30-year-old and a frail 80-year-old could have the same creatinine level while their actual kidney function is very different.

Diet matters too. A study in people with diabetes-related kidney disease found that eating a single cooked meat meal caused a significant rise in serum creatinine and a corresponding drop in eGFR. Six of 16 patients at one stage of kidney disease were misclassified into a worse stage after the meal. The effect disappeared after about 12 hours of fasting.⁵ This is why some labs recommend fasting or at least avoiding a heavy meat meal before bloodwork, though not every clinic enforces it. If your eGFR result seems unexpectedly low, it is worth asking whether your last meal could have played a role.

Cystatin C as an Alternative Marker

Cystatin C is a small protein produced by virtually all cells in the body, and the kidneys filter it at a steady rate. Unlike creatinine, cystatin C is largely unaffected by muscle mass, physical activity, or diet, which makes it a useful backup when creatinine-based estimates seem unreliable.

In large population studies, cystatin C-based eGFR reclassifies a meaningful number of people compared with creatinine alone. One pooled analysis of general-population cohorts found that the share of people with an eGFR below 60 was higher when estimated by cystatin C than by creatinine (about 14% versus about 10%), suggesting creatinine alone misses some cases of reduced kidney function.⁶ Interestingly, the same research from the lean-mass study mentioned earlier found that cystatin C did not correlate with lean mass the way creatinine did, even after adjusting for diet and exercise.⁴

Cystatin C is not yet standard on every renal panel. It tends to be ordered as a confirmatory test when a creatinine-based eGFR seems discordant with the clinical picture, such as when someone with low muscle mass shows a “normal” creatinine but their doctor suspects kidney trouble. The 2021 CKD-EPI equations that combine creatinine and cystatin C together are considered the most accurate option currently available for estimating GFR across diverse populations.²

Electrolytes and Acid-Base Balance on the Panel

The electrolyte portion of a renal panel often gets less attention than creatinine and eGFR, but it carries important information. Potassium is probably the most clinically urgent electrolyte the kidneys regulate. When kidney function drops, potassium can accumulate in the blood, a condition that can cause dangerous heart rhythm problems if it goes unchecked. The kidney’s loop of Henle and collecting ducts are the main sites where potassium handling is fine-tuned. Animal research has shown that when the body is depleted of potassium, the loop of Henle ramps up potassium reabsorption, and when potassium intake is high, both potassium and sodium absorption are dampened.⁷ This is relevant for patients on medications like calcineurin inhibitors (commonly used after organ transplants), which can disrupt these transport systems and lead to high potassium levels.⁸

Chloride and bicarbonate are reported as part of the acid-base picture. The kidneys reclaim the vast majority of filtered bicarbonate, roughly 85 to 90% in the early part of the tubule system, with the rest picked up further along.⁹ When kidney disease progresses, this reclamation falters and bicarbonate levels fall while chloride may rise, tilting the body toward acidosis. If your panel shows low bicarbonate and high chloride together, your doctor will likely investigate whether your kidney disease is worsening or whether another process is responsible.

Calcium, Phosphorus, and Bone Health

In healthy kidneys, calcium and phosphorus stay in a tightly controlled range. The kidneys activate vitamin D, which helps absorb calcium from food, and they excrete excess phosphorus. As kidney function declines, phosphorus builds up in the blood because the kidneys can no longer clear it efficiently. The body compensates by pulling calcium from bones, which over time can lead to weakened bones and calcification of blood vessels.

This is why a renal function panel often includes both calcium and phosphorus, especially for people already diagnosed with kidney disease. Keeping the calcium-phosphorus product (a rough measure of how much mineral is floating in the blood) under control is a key management goal. In hemodialysis patients with high phosphorus, treatments like phosphate binders are standard, and adjunct strategies such as adding niacin to a phosphate-binder regimen have shown promise, with one trial reporting a 30% reduction in serum phosphorus and a 37% drop in the calcium-phosphorus product over two months.¹⁰

Why Urine Tests Often Accompany the Blood Panel

A renal function panel is a blood test, but your doctor may also order a urine test at the same time, most commonly the urine albumin-to-creatinine ratio (UACR). This measures tiny amounts of the protein albumin leaking into the urine, which is one of the earliest signs of kidney damage, often appearing before creatinine or eGFR show any abnormality.

Research consistently shows that combining eGFR with UACR is far more informative than either measure alone. A large study found that people identified as having chronic kidney disease by all three markers (creatinine, cystatin C, and urine albumin) had more than five times the risk of death compared with those classified by creatinine alone.¹¹ Similarly, work on predicting progression to end-stage kidney disease has demonstrated that adding UACR to eGFR substantially improves diagnostic accuracy at every level of reduced kidney function.¹²

Despite these benefits, urine albumin testing remains underused. A real-world analysis of screening patterns in people with type 2 diabetes found that while 55% had their eGFR checked within a year, only 29% had a UACR test done.¹³ In a community screening follow-up study, adding first-morning UACR to the standard eGFR and dipstick screening turned up substantial previously undetected albuminuria and changed the risk classification for a meaningful number of participants.¹⁴ If you have diabetes, high blood pressure, or a family history of kidney disease and your doctor has only been checking your blood, it is reasonable to ask about adding a UACR.

Kidney Panels During Pregnancy

Pregnancy reshapes kidney function in ways that can confuse standard reference ranges. Blood volume increases significantly, which boosts the kidneys’ filtration rate and drives creatinine levels down. In uncomplicated pregnancies, serum creatinine tends to be about 30% lower than in non-pregnant women, with the lowest values typically appearing in the second trimester. One study found the 97.5th percentile for creatinine in the second trimester was 0.52 mg/dL, compared with 0.82 mg/dL in non-pregnant women.¹⁵

This matters clinically because a creatinine value that looks “normal” by standard adult ranges might actually be elevated for a pregnant woman. A study in African women found the upper limit of normal for creatinine during pregnancy was about 20% lower than six months after delivery, while estimated creatinine clearance was roughly 35% higher during pregnancy.¹⁶ If you are pregnant and see a creatinine level that seems fine by the reference range printed on your lab report, keep in mind that those ranges were not designed for pregnancy. Your obstetrician or midwife should be interpreting the values with pregnancy-specific thresholds in mind.

Point-of-Care Kidney Testing

Sometimes you need a quick read on kidney function, particularly in emergency rooms or radiology departments where contrast dye is about to be injected. Point-of-care (POC) devices can measure creatinine from a finger-prick blood sample in a few minutes rather than the hour or more a central lab might take. A study evaluating two common POC devices found they were moderately accurate at detecting kidney impairment and did not miss any high-risk patients. However, they tended to underreport eGFR in some cases, meaning they flagged some patients as having worse kidney function than lab testing later confirmed.¹⁷ In practical terms, POC devices are good as a screening gate: if the result looks normal, you can proceed with confidence. If it comes back low, it is worth confirming with a full lab draw before making treatment decisions.

When and Why Your Doctor Orders This Panel

A renal function panel is not reserved for people with known kidney problems. It is a routine part of preventive care for anyone with diabetes, high blood pressure, heart disease, or a family history of kidney disease. It also shows up in pre-surgical evaluations, medication monitoring (many drugs are cleared by the kidneys, and doses need adjusting if kidney function is low), and hospital admissions for acute illness.

If you are on medications like ACE inhibitors, ARBs, NSAIDs, or certain antibiotics, periodic renal panels help catch drug-related kidney stress early. The same goes for people taking calcineurin inhibitors after organ transplants, where disrupted potassium handling can become a serious issue. For people with established chronic kidney disease, the panel is tracked over time to detect progression. Trends matter more than any single snapshot: a creatinine level that has crept up steadily over a year is more concerning than an isolated high reading that could reflect dehydration or a recent steak dinner.

One underappreciated use of the renal panel is in staging kidney disease. The international KDIGO staging system classifies chronic kidney disease by combining eGFR categories with albuminuria categories into a risk grid. A person with an eGFR of 50 and normal albumin excretion has a different prognosis and management plan than someone with the same eGFR but heavy albuminuria. This is precisely why nephrologists emphasize that eGFR alone does not tell the full story and advocate for routine urine albumin measurement alongside the blood panel.¹²

How to Read Your Results Without Panicking

Lab reports can look intimidating, but a few principles help. First, look at eGFR rather than raw creatinine. The eGFR calculation already accounts for age and sex, so it gives you a more meaningful number than creatinine on its own. An eGFR above 90 with no protein in the urine is generally reassuring. Values between 60 and 89 are common in older adults and do not automatically mean disease, especially if they have been stable for years. Below 60 is where most guidelines define chronic kidney disease, though a single reading needs confirmation.

Second, pay attention to the trend. A stable creatinine of 1.2 mg/dL over five years is very different from a creatinine that jumped from 0.9 to 1.2 in six months. Labs often include prior values for comparison, and if yours does not, ask your doctor to pull up your history.

Third, context matters for every single number. Low bicarbonate might reflect kidney disease, but it can also show up after severe diarrhea. High potassium sometimes results from the blood sample sitting too long before processing, a lab artifact rather than a real problem. Low calcium on the report might actually be normal if your albumin is also low, since labs measure total calcium and a chunk of it rides on albumin. Your doctor adjusts for these things, which is why self-diagnosing from an online reference range rarely works well.

Finally, if a result looks off and you recently ate a large meat meal, were dehydrated, or had an unusually intense workout, mention that. These everyday factors can shift creatinine and BUN enough to nudge your results out of normal ranges without reflecting any actual kidney problem.⁵ A repeat test under more controlled conditions usually clears things up.

1
Boston Congress of Public Health Review (BCPHR, Formerly HPHR). Comparison of eGFR Outcomes in Black Populations Using the 2009 CKD-EPI with Race Adjustment Equation and the 2021 CKD-EPI without Race Modifier Equation: A Review
2
PubMed Central. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race
3
Cukurova Medical Journal. New analysis of the comparative diagnostic performances of five different eGFR equations
4
PubMed Central. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C
5
PubMed. Effect of a cooked meat meal on serum creatinine and estimated glomerular filtration rate in diabetes-related kidney disease
6
PubMed Central. Cystatin C versus creatinine in determining risk based on kidney function
7
PubMed. Potassium and sodium transport along the loop of Henle: effects of altered dietary potassium intake
8
PubMed Central. Role of calcineurin in regulating renal potassium (K+) excretion: Mechanisms of calcineurin inhibitor-induced hyperkalemia
9
PubMed Central. The ratio of chloride to bicarbonate is a predictor of advanced metabolic acidosis in CKD stages G4 and G5
10
Research Journal of Pharmacy and Technology. Potential role of Niacin as Adjuvant to Sevelamer on Serum levels of Inorganic phosphorus, Calcium and Calcium-phosphorus product in Hemodialysis patients with Hyperphosphatemia
11
PubMed Central. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality
12
PubMed Central. Combining GFR and albuminuria to classify CKD improves prediction of ESRD
13
Diabetes. 1408-P: Chronic Kidney Disease (CKD) Screening in Type 2 Diabetes (T2DM): A Real-World Analysis of Estimated Glomerular Filtration Rate (eGFR) and Urine Albumin–Creatinine Ratio (uACR) Testing Patterns
14
PubMed. Urine Albumin-to-Creatinine Ratio Reveals Kidney Disease Improving Global Outcomes Risk Reclassification in Cardiovascular-Kidney-Metabolic-Era Community Screening
15
PubMed Central. Maternal Renal Function During Pregnancy and the Early Postpartum Period in Normotensive and Hypertensive Pregnancies
16
PubMed. Development of normal reference intervals for renal function in pregnancy: a secondary analysis of clinical trial data
17
PubMed. Is point of care renal function testing reliable screening pre-IV contrast administration?